Strategy Asset Managers LLC lifted its stake in shares of KKR & Co. Inc. (NYSE:KKR – Free Report) by 25.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,968 shares of the asset manager’s stock after buying an additional 1,412 shares during the quarter. Strategy Asset Managers LLC’s holdings in KKR & Co. Inc. were worth $1,031,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. AdvisorNet Financial Inc increased its stake in shares of KKR & Co. Inc. by 417.8% in the 4th quarter. AdvisorNet Financial Inc now owns 2,180 shares of the asset manager’s stock worth $322,000 after acquiring an additional 1,759 shares in the last quarter. Whalen Wealth Management Inc. purchased a new stake in shares of KKR & Co. Inc. during the fourth quarter valued at $667,000. Caldwell Investment Management Ltd. lifted its stake in KKR & Co. Inc. by 2.9% during the 4th quarter. Caldwell Investment Management Ltd. now owns 212,400 shares of the asset manager’s stock valued at $31,477,000 after acquiring an additional 5,900 shares during the period. Jupiter Asset Management Ltd. grew its stake in shares of KKR & Co. Inc. by 50.9% in the fourth quarter. Jupiter Asset Management Ltd. now owns 114,184 shares of the asset manager’s stock worth $16,889,000 after acquiring an additional 38,524 shares during the period. Finally, Sanctuary Advisors LLC raised its holdings in shares of KKR & Co. Inc. by 31.1% during the third quarter. Sanctuary Advisors LLC now owns 92,741 shares of the asset manager’s stock valued at $12,110,000 after purchasing an additional 22,007 shares during the last quarter. Hedge funds and other institutional investors own 76.26% of the company’s stock.
Analyst Ratings Changes
A number of analysts recently commented on KKR shares. HSBC cut KKR & Co. Inc. from a “buy” rating to a “hold” rating and upped their price objective for the company from $153.00 to $173.00 in a research report on Thursday, January 30th. Morgan Stanley dropped their price objective on KKR & Co. Inc. from $157.00 to $156.00 and set an “equal weight” rating for the company in a research note on Thursday, February 6th. Wells Fargo & Company raised shares of KKR & Co. Inc. from an “equal weight” rating to an “overweight” rating and cut their target price for the company from $150.00 to $141.00 in a research note on Thursday, March 20th. Barclays cut their price target on KKR & Co. Inc. from $185.00 to $181.00 and set an “overweight” rating for the company in a report on Wednesday, February 5th. Finally, Hsbc Global Res downgraded shares of KKR & Co. Inc. from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 30th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, KKR & Co. Inc. presently has a consensus rating of “Moderate Buy” and an average target price of $160.79.
KKR & Co. Inc. Price Performance
NYSE KKR opened at $114.90 on Friday. KKR & Co. Inc. has a 52-week low of $91.92 and a 52-week high of $170.40. The firm’s 50 day moving average price is $136.07 and its 200-day moving average price is $141.36. The company has a market cap of $102.06 billion, a PE ratio of 34.51, a P/E/G ratio of 1.00 and a beta of 1.72. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.07 and a current ratio of 0.07.
KKR & Co. Inc. Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were issued a $0.175 dividend. This represents a $0.70 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date of this dividend was Friday, February 14th. KKR & Co. Inc.’s dividend payout ratio is currently 21.02%.
Insiders Place Their Bets
In other news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $32.96, for a total value of $197,760,000.00. Following the transaction, the insider now directly owns 19,260,971 shares of the company’s stock, valued at approximately $634,841,604.16. This represents a 23.75 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 39.34% of the company’s stock.
About KKR & Co. Inc.
KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.
See Also
- Five stocks we like better than KKR & Co. Inc.
- Short Selling – The Pros and Cons
- 4 Healthcare Stocks With Massive Gains—and More to Come
- Investing in Travel Stocks Benefits
- Affirm Strikes Back: Can a New Deal Mitigate the Recent Loss?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
Want to see what other hedge funds are holding KKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for KKR & Co. Inc. (NYSE:KKR – Free Report).
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.